Events

MoBioC 2022 Seminar Series: Dr Helena W. Snyder (Cambridge Medical Technologies)

Dr Helena W. Snyder, Vice President, Electrochemistry, Cambridge Medical Technologies

Date: 26 January 2022   Time: 14:00 - 15:00

Point-of-Care (POC) Biosensing and Targeted Nanoscale Drug Delivery
Dr Helena W. Snyder, Vice President, Electrochemistry, Cambridge Medical Technologies

POC sensing, and particularly wearable, continuous at-home monitoring has been garnering increased research and commercial interest in recent years after the commercial successes of several wearable glucose monitoring devices using microneedles. Dr. Helena Snyder is Vice President of Electrochemistry at Cambridge Medical Technologies, a medical device company specializing in non-invasive POC sampling and bioanalysis of interstitial fluid, without the use of microneedles. The first half of the seminar will introduce this technology and describe some of the company's current research focuses. The second half of the seminar will focus on targeted nano-liposomal drug delivery, a fast expanding research area, which is expected to explode in coming years, especially after the phenomenal success of the nano-lipid-encapsulated mRNA COVID-19 vaccines. Dr. Snyder is interested in marrying these two areas of research toward the development of closed loop sensing/drug delivery systems and personalized medicine.

Updated by: Julien Gautrot